← All candidates
43 insider filings on record.
43 filings on record.
OLMAOlema Pharmaceuticals, Inc.
NasdaqGS · Healthcare · $855.73M
$10.29
+0.68% · Sep 14
43 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 26 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$855.73M
Float
59.2M
68% public
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
38 more transactions on Pro →Context
Wall St
$40.70 avg target
+295.5% vs today · 10 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.52 act+$0.02
Q4 '25−$0.50 act+$0.03
Q3 '25−$0.49 act−$0.04
Q2 '25−$0.51 act−$0.07
Coverage
Does Olema Pharmaceuticals' (OLMA) Broad Russell Growth Inclusion Reveal a Turning Point in Its Investor Story?Simply Wall St. · 06-30How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer BetInsider Monkey · 06-17Olema’s OP-3136 Data Draw Focus To Oncology Pipeline And Valuation GapSimply Wall St. · 05-25Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 StudyStocktwits · 05-22
The file stays open
43 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice